What is it about?

the outcome of transplant recipients was assessed in relation to the optimal or suboptimal use of Ganciclovir or Valganciclovir

Featured Image

Why is it important?

Any incorrect use of the drug may have serious consequences for patients

Perspectives

it seems necessary to advocate use of standard treatment guidelines to avoid adverse outcomes

Shirinsadat Badri
Isfahan University of Medical Sciences

Read the Original

This page is a summary of: Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?, Journal of Transplantation, September 2018, Hindawi Publishing Corporation,
DOI: 10.1155/2018/8414385.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page